ARKK Holdings of FATE
Fate Therapeutics
FATE Therapeutics is a biopharmaceutical company that develops cellular immunotherapy treatments aimed at treating cancer and immune disorders. The company generates revenue through sales of its therapeutic products and by entering into collaborations and partnerships with other biotech firms and research institutions to advance its innovative treatments.
Trades of FATE in ARKK
The ten most recent trades of Fate Therapeutics in the ARKK ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 10, 2023 | Sell | $5,940 | 100.00% | 0.00% |
| Jan 06, 2023 | Sell | $81,826 | 34.48% | 0.00% |
| Jan 03, 2023 | Sell | $11,888,082 | 81.44% | 0.20% |
| Dec 29, 2022 | Sell | $28,155,265 | 45.46% | 0.49% |
| Dec 28, 2022 | Sell | $1,437,443 | 2.24% | 0.02% |
| Dec 27, 2022 | Sell | $2,907,043 | 4.16% | 0.05% |
| Dec 21, 2022 | Sell | $1,636,485 | 1.86% | 0.03% |
| Aug 15, 2022 | Buy | $5,615 | 0.00% | 0.00% |
| Aug 12, 2022 | Buy | $118,322 | 0.05% | 0.00% |
| Aug 11, 2022 | Buy | $15,760,648 | 6.88% | 0.15% |